Willems, M. (2023). Eosinophils inhibit response to chemotherapy: mechanisms, preclinical and clinical study in mesothelioma [Doctoral thesis, ULiège. GxABT - Liège Université. Gembloux Agro-Bio Tech]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/306186 |
Willems, M. (27 June 2023). In vitro, preclinical and patients’ data evidence for a role of eosinophils in mesothelioma response to chemotherapy [Paper presentation]. International Mesothelioma interest Group, Lille, France. |
Willems, M., & Willems, L. (08 February 2023). Eosinophils inhibit response to therapy: mechanisms and preclinical study in mesothelioma [Paper presentation]. GIGA-Cancer seminars, Liège, Belgium. |
Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798 * These authors have contributed equally to this work. |
Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma [Poster presentation]. Giga Cancer Day, Liège, Belgium. * These authors have contributed equally to this work. |
Willems, M., Jamakhani, M., Scherpereel, A., Wasielewski, E., Brossel, H., Fontaine, A., Hoyos, C., Grégoire, M., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Eosinophils inhibit malignant pleural mesothelioma response to chemotherapy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium. * These authors have contributed equally to this work. |
Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211 |
Willems, M., & Willems, L. (20 November 2020). Eosinophils inhibit mesothelioma chemotherapy [Paper presentation]. GIGA-Cancer Seminars, Liège, Belgium. |
Willems, M., Willems, L., & Hamaïdia, M. (November 2019). Influence des éosinophiles sur la réponse des cellules de mésothéliome pleural malin à la chimiothérapie [Poster presentation]. 2èmes Journées Francophones sur le Mésothéliome, Nantes, France. |
Willems, M., Willems, L., & Hamaïdia, M. (November 2019). Influence des éosinophiles sur la réponse des cellules de mésothéliome pleural malin à la chimiothérapie [Paper presentation]. 2ème Journées Francophones sur le Mésothéliome, Nantes, France. |